135 related articles for article (PubMed ID: 36468785)
1. Inflammatory chemokine (C-C motif) ligand 8 inhibition ameliorates peritoneal fibrosis.
Lee Y; Lee J; Park M; Seo A; Kim KH; Kim S; Kang M; Kang E; Yoo KD; Lee S; Kim DK; Oh KH; Kim YS; Joo KW; Yang SH
FASEB J; 2023 Jan; 37(1):e22632. PubMed ID: 36468785
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-C Motif) Ligand 8 and Tubulo-Interstitial Injury in Chronic Kidney Disease.
Lee J; Lee Y; Kim KH; Kim DK; Joo KW; Shin SJ; Kim YS; Yang SH
Cells; 2022 Feb; 11(4):. PubMed ID: 35203308
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells.
Shi SS; Zhang YQ; Zhang LQ; Li YF; Zhou XS; Li RS
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38483736
[TBL] [Abstract][Full Text] [Related]
5. ST2 blockade mitigates peritoneal fibrosis induced by TGF-β and high glucose.
Kim YC; Kim KH; Lee S; Jo JW; Park JY; Park MS; Tsogbadrakh B; Lee JP; Lee JW; Kim DK; Oh KH; Jang IJ; Kim YS; Cha RH; Yang SH
J Cell Mol Med; 2019 Oct; 23(10):6872-6884. PubMed ID: 31397957
[TBL] [Abstract][Full Text] [Related]
6. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.
Maeda K; Doi S; Nakashima A; Nagai T; Irifuku T; Ueno T; Masaki T
PLoS One; 2017; 12(3):e0173706. PubMed ID: 28278257
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model.
Yoshimine H; Tanoue S; Ibi Y; Minami M; Nakahara M; Tokunaga K; Kanmura S; Ido A
Clin Exp Nephrol; 2021 Sep; 25(9):935-943. PubMed ID: 33909175
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology and adeno-associated virus-based decorin gene therapy ameliorates peritoneal fibrosis.
Chaudhary K; Moore H; Tandon A; Gupta S; Khanna R; Mohan RR
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F777-82. PubMed ID: 25056353
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a novel mouse peritoneal dialysis-associated peritoneal injury model.
Yu F; Chen J; Wang X; Cai Q; Luo J; Wang L; Chen K; He Y
Clin Exp Nephrol; 2022 Jul; 26(7):649-658. PubMed ID: 35353282
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis.
Honda F; Tsuboi H; Ono Y; Abe S; Takahashi H; Ito K; Yamada K; Kawano M; Kondo Y; Asano K; Tanaka M; Malissen M; Malissen B; Matsumoto I; Sumida T
Arthritis Res Ther; 2021 Aug; 23(1):214. PubMed ID: 34391459
[TBL] [Abstract][Full Text] [Related]
14. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
15. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells.
Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989
[TBL] [Abstract][Full Text] [Related]
16. CXCR4-Receptor-Targeted Liposomes for the Treatment of Peritoneal Fibrosis.
Asifullah K; Zhou Z; He W; Gao K; Khan MW; Faisal R; Muhammad H; Sun M
Mol Pharm; 2019 Jun; 16(6):2728-2741. PubMed ID: 31070930
[TBL] [Abstract][Full Text] [Related]
17. Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis.
Xie S; Xu F; Lu Y; Zhang Y; Li X; Yu M; Cui W
Front Pharmacol; 2022; 13():890881. PubMed ID: 35800446
[TBL] [Abstract][Full Text] [Related]
18. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
19. IL-6
Yang X; Yan H; Jiang N; Yu Z; Yuan J; Ni Z; Fang W
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F338-F353. PubMed ID: 31841386
[TBL] [Abstract][Full Text] [Related]
20. WNT signaling is required for peritoneal membrane angiogenesis.
Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
